cholesterol
major
compon
plasma
membran
lipid
raft
import
assembl
bud
envelop
virus
includ
influenza
cholesterol
deplet
impair
viru
assembl
infect
studi
examin
effect
exogen
cholesterol
addit
deliv
complex
methyl
beta
cyclodextrin
product
moloni
murin
leukemia
viru
retrovir
vector
lentivir
vector
pseudotyp
vesicular
stomat
viru
glycoprotein
vsvg
cholesterol
supplement
vector
product
enhanc
infect
retrovir
lentivir
vector
respect
contrast
amount
retrovir
vector
produc
unchang
lentivir
vector
increas
less
twofold
free
cholesterol
cholesterol
ester
content
produc
cell
increas
cholesterol
addit
contrast
phospholipid
headgroup
composit
essenti
unchang
cholesterol
supplement
packag
cell
base
result
propos
cholesterol
supplement
increas
infect
vsvgpseudotyp
retrovir
lentivir
vector
possibl
alter
composit
produc
cell
membran
viral
vector
assembl
bud
andor
chang
lipid
composit
viral
vector
cell
membran
microdomain
call
lipid
raft
essenti
assembl
sever
envelop
virus
influenza
ebola
rotavirus
newcastl
diseas
viru
import
properti
lipid
raft
preferenti
includ
exclud
particular
protein
variabl
extent
two
major
transmembran
glycoprotein
influenza
virus
hemagglutinin
neuraminidas
raftassoci
protein
also
lipid
bilay
viru
contain
gpilink
protein
gangliosid
known
partit
preferenti
lipid
raft
convers
nonraft
protein
exclud
lipid
bilay
virus
studi
shown
gag
env
protein
raftassoci
protein
cholesterol
sphingolipid
essenti
format
stabil
lipid
raft
level
elev
lipid
raft
isol
mammalian
cell
cholesterol
supplement
shown
increas
percentag
hemagglutinin
neuraminidas
associ
lipid
raft
mdck
cell
infect
influenza
viru
cholesterol
deplet
disrupt
lipid
raft
abrog
associ
raftassoci
protein
disrupt
lipid
raft
cholesterol
deplet
hinder
particl
product
virusproduc
cell
cholesterol
deplet
viru
particl
significantli
impair
viru
infect
deplet
cholesterol
target
cell
impair
viru
infect
decreas
mobil
coreceptor
cell
surfac
investig
found
disrupt
lipid
raft
also
decreas
product
vsvgpseudotyp
pantrop
moloni
murin
leukemia
viru
momulv
vector
cholesterol
supplement
shown
enhanc
viral
infect
nonvir
transfect
exampl
cholesterol
supplement
increas
suscept
target
cell
infect
envelop
coronaviru
murin
hepat
viru
human
adenoviru
similarli
addit
cholesterol
liposom
transfect
increas
overal
effici
nonvir
gene
deliveri
benefit
might
due
impact
cholesterol
cell
membran
fluiditi
cholesterol
addit
result
compensatori
increas
fraction
polyunsatur
fatti
acid
phosphatidylcholin
phosphatidylethanolamin
phosphatidylserin
control
membran
fluiditi
beer
et
al
observ
higher
cholesterol
level
membran
produc
cell
momulv
viral
vector
produc
cell
cultur
compar
suggest
cell
may
counteract
decreas
membran
fluiditi
lower
temperatur
increas
cholesterol
content
cell
membran
curious
also
report
decreas
vector
stabil
correl
higher
level
cholesterol
viral
vector
membran
multipl
report
neg
correl
cholesterol
deplet
process
viru
product
infect
decid
test
whether
cholesterol
supplement
would
affect
viral
vector
product
infect
made
use
retrovir
lentivir
vector
system
previous
describ
us
unless
otherwis
note
reagent
obtain
sigmaaldrich
st
loui
mo
cell
atcc
manassa
va
maintain
dulbecco
modifi
eagl
medium
high
glucos
dmem
mediatech
inc
cellgro
herndon
va
supplement
fetal
bovin
serum
fb
omega
scientif
inc
tarzana
ca
fetalplex
serum
fp
gemini
bioproduct
woodland
ca
iuml
penicillin
streptomycin
mediatech
inc
cellgro
cell
maintain
medium
invitrogen
carlsbad
ca
supplement
fb
hyclon
logan
ut
cell
line
develop
adapt
cell
suspens
cultur
hela
cell
atcc
maintain
iscov
modifi
dulbecco
medium
imdm
irvin
scientif
santa
ana
ca
supplement
fb
hyclon
pvsvg
encod
pantrop
vsvg
envelop
protein
open
read
frame
egfp
introduc
deriv
plxsn
larg
multipl
clone
site
plasmid
refer
pltregfp
report
cell
seed
cell
dish
ml
dmem
supplement
fb
fp
penicillin
streptomycin
hour
transfect
total
plasmid
pvsvg
pltregfp
transfect
cell
use
invitrogen
plasmid
ratio
previous
shown
us
give
high
transduct
effici
fresh
medium
exchang
hour
transfect
afterward
ml
fresh
medium
exchang
cultur
everi
hour
supernat
collect
hour
centrifug
rcf
eight
minut
remov
cell
debri
store
call
st
nd
collect
respect
produc
lentivir
vector
pseudotyp
vsvg
suspens
cultur
cell
seed
ml
fresh
medium
supplement
fb
shake
flask
induc
addit
mm
sodium
butyr
doxycyclin
cell
densiti
induct
viabl
cellsml
fresh
medium
supplement
sodium
butyr
doxycylcin
exchang
everi
hour
induct
supernat
filter
filter
store
supernat
collect
hour
induct
call
st
nd
collect
respect
cholesterol
ad
cultur
differ
time
point
andor
vector
product
deliv
complex
methylbetacyclodextrin
directli
dissolv
medium
mole
percentag
cholesterol
complex
cholesterol
supplement
scheme
use
studi
shown
figur
hela
cell
seed
cell
per
well
dmem
imdm
supplement
fb
fp
plate
hour
transduct
viral
vector
store
thaw
use
transduct
differ
proport
viral
vector
use
transduct
balanc
fresh
medium
overal
amount
transduct
medium
ml
polybren
use
transduct
transduct
medium
replac
fresh
medium
hour
transduct
hour
transduct
target
cell
remov
trypsinedta
suspend
dmem
supplement
fb
fp
analyz
facscan
becton
dickinson
franklin
lake
nj
egfpexpress
cell
egfpposit
cell
judg
cell
fluoresc
intens
seen
nontransduc
cell
channel
momulv
vector
transduct
effici
rang
determin
use
dilut
partial
dilut
vector
lentivir
vector
report
result
term
titer
rather
transduct
effici
dilut
vector
use
studi
briefli
supernat
contain
retrovir
vector
pellet
ultracentrifug
rpm
rotor
beckman
ultracentrifug
fullerton
ca
sucros
cushion
one
hour
resuspend
phosphatebuff
salin
pb
vector
lyse
use
lysi
buffer
mm
tri
hcl
ph
mm
nacl
mm
edta
sodium
dodecyl
sulfat
sodium
deoxychol
triton
sodium
azid
mix
sampl
buffer
sampl
buffer
wv
sodium
dodecyl
sulphat
sd
mm
trishcl
ph
vv
glycerol
wv
bromphenol
blue
betamercaptoethanol
boil
load
sdspolyacrylamid
gel
electrophoresi
page
gel
separ
protein
band
transfer
onto
immunoblot
pvdf
membran
biorad
hercul
ca
membran
block
milk
solut
gdl
dri
milk
pb
hybrid
primari
rabbit
anti
gag
antibodi
kindli
provid
dr
rein
nation
cancer
institut
peroxidaseconjug
secondari
antibodi
goat
antirabbit
jackson
immunoresearch
laboratori
inc
west
grove
pa
briefli
wash
tween
pb
membran
wash
deioniz
water
analyz
use
convent
chemiluminesc
method
capsid
protein
lentivir
vector
measur
follow
manufactur
instruct
use
commerci
elisa
kit
nen
life
scienc
product
boston
lipid
raft
nonraft
membran
fraction
separ
use
equilibrium
floatat
centrifug
describ
ono
briefli
cell
seed
dish
hour
assay
cell
wash
cold
pb
scrape
cold
fb
cell
centrifug
resuspend
te
mm
trishcl
ph
mm
edta
plu
proteas
inhibitor
cell
homogen
sonic
homogen
centrifug
remov
nuclei
postnuclear
supernat
treat
without
vv
triton
tne
solut
mm
trishcl
ph
mm
nacl
mm
edta
incub
min
ice
supernat
mix
ml
wv
sucros
solut
tne
place
ultracentrifug
tube
ml
w
v
ml
wv
sucros
solut
tne
load
top
sucros
gradient
centrifug
rpm
hour
rotor
beckman
ultracentrifug
twenti
fraction
supernat
collect
centrifug
mix
ripa
buffer
igep
wv
sodium
deoxychol
sodium
dodecyl
sulfat
pb
sampl
store
lipid
extract
procedur
modif
bligh
dyer
procedur
briefli
cell
trypsin
wash
pb
cell
resuspend
ml
h
contain
mm
nacl
mm
edta
dispos
glass
tube
one
ml
methanol
ml
chloroform
ad
tube
vortex
briefli
addit
ad
chloroform
mixtur
allow
stand
second
vortex
ml
chloroform
ml
h
sequenti
ad
tube
vortex
briefli
addit
tube
centrifug
rcf
room
temperatur
separ
chloroform
aqueou
layer
chloroform
layer
contain
lipid
transfer
glass
tube
use
pasteur
pipett
anoth
ml
chloroform
ad
origin
tube
tube
vortex
centrifug
chloroform
layer
extract
combin
first
exact
store
nitrogen
chloroform
layer
dri
nitrogen
room
temperatur
extract
dissolv
chloroform
extract
load
onto
preheat
thin
layer
chromatographi
plate
whatman
florham
park
nj
plate
develop
solvent
system
chloroform
methanol
acet
acid
nacl
vv
minut
run
phospholipid
visual
exposur
iodin
vapor
identifi
help
authent
standard
run
plate
scrape
tlc
plate
use
razor
blade
differ
glass
tube
phospholipid
fraction
digest
perchlor
acid
min
mixtur
allow
cool
room
temperatur
fume
hood
color
develop
essenti
accord
modifi
bartlett
procedur
briefli
ml
dh
ammonium
molybd
acid
ansa
ad
sequenti
tube
vortex
place
boil
water
min
cool
tube
centrifug
rcf
min
mixtur
ad
well
plate
absorb
read
nm
use
biotek
synergi
ht
micropl
reader
biotek
instrument
winooski
vt
phosphoru
content
determin
convert
absorb
concentr
use
standard
curv
employ
kh
po
standard
chloroform
lipid
extract
dri
nitrogen
room
temperatur
extract
dissolv
isopropanol
total
free
cholesterol
content
determin
use
cholesterol
e
free
cholesterol
c
kit
wako
richmond
va
accord
manufactur
instruct
biotek
synergi
ht
micropl
reader
p
valu
studi
obtain
use
twotail
unpair
ttest
equal
varianc
lipid
raft
shown
involv
assembl
sever
envelop
virus
includ
influenza
ebola
investig
associ
momulv
gag
protein
lipid
raft
use
equilibrium
floatat
centrifug
untransfect
cell
supplement
without
mm
cholesterol
homogen
sonic
supernat
treat
without
triton
cell
lysat
load
discontinu
sucros
gradient
solut
centrifug
lipid
raft
associ
gag
protein
float
top
fraction
gradient
figur
also
contain
major
wellknown
lipid
raftassoci
protein
calveolin
data
shown
lipid
raft
float
top
gradient
detergentresist
microdomain
drm
combin
fact
raft
typic
constitut
less
cell
membran
result
suggest
coloc
raft
momulv
gag
cell
expect
associ
gag
drm
disrupt
treatment
triton
gag
protein
found
bottom
fraction
gradient
figur
test
effect
cholesterol
supplement
transduct
effici
cell
use
momulv
vector
produc
transfect
cell
first
examin
differ
dose
cholesterol
provid
cell
hour
transfect
maintain
cultur
vector
product
supplement
mm
cholesterol
increas
transduct
effici
cell
vector
collect
st
nd
collect
tabl
increas
st
collect
nd
collect
supplement
mm
cholesterol
littl
effect
contrast
supplement
mm
cholesterol
greatli
inhibit
produc
cell
growth
data
shown
thu
result
low
transduct
effici
explor
optim
addit
time
mm
cholesterol
supplement
produc
cell
cultur
use
differ
scheme
tabl
effect
cholesterol
addit
use
variou
time
scheme
better
demonstr
st
collect
nd
collect
supplement
cholesterol
transfect
led
higher
transduct
effici
compar
scheme
without
addit
cholesterol
transfect
especi
st
collect
gener
addit
mm
cholesterol
transfect
gave
highest
transduct
effici
therefor
use
rest
studi
like
transduct
effici
could
increas
extens
optim
cholesterol
dose
eg
mm
andor
incub
time
benefici
effect
cholesterol
supplement
evalu
use
two
differ
sera
fetal
bovin
serum
fb
fetalplex
serum
fp
concentr
gener
benefit
cholesterol
supplement
condit
although
foldincreas
transduct
effici
differ
differ
condit
figur
fb
increas
transduct
effici
cholesterol
addit
greater
nd
collect
st
collect
figur
tabl
less
differenti
benefit
nd
collect
fp
especi
concentr
figur
tabl
rel
increas
transduct
effici
use
vector
collect
cultur
cholesterol
supplement
compar
without
cholesterol
addit
greater
lower
absolut
transduct
effici
control
condit
expect
higher
valu
control
transduct
effici
alreadi
approach
maximum
possibl
system
cell
number
maintain
increas
slightli
transfect
without
cholesterol
supplement
compar
control
cultur
cell
number
cultur
cholesterol
slightli
lower
data
shown
thu
observ
increas
transduct
effici
cholesterol
supplement
attribut
increas
produc
cell
number
sinc
cholesterol
also
present
supernat
viral
vector
vector
product
transduct
possibl
benefici
effect
cholesterol
supplement
transduct
effici
due
part
either
interact
viral
vector
cholesterol
vector
assembl
effect
transduct
process
examin
possibl
viral
vector
produc
control
condit
either
incub
mm
cholesterol
hour
transduct
supplement
concentr
cholesterol
transduct
benefit
slight
decreas
either
treatment
viral
vector
produc
cholesterol
supplement
yield
increas
transduct
effici
figur
indic
cholesterol
must
ad
vector
product
obtain
benefit
cholesterol
deliv
cell
cultur
complex
methylbetacyclodextrin
mbcd
evalu
effect
mbcd
alon
vector
product
mm
mbcd
concentr
complex
cholesterol
ad
produc
cell
transfect
mbcd
alon
littl
effect
transduct
effici
figur
expect
higher
concentr
empti
mbcd
mm
greatli
decreas
transduct
effici
even
expos
produc
cell
hour
figur
insert
next
examin
total
amount
vector
produc
determin
amount
gag
without
cholesterol
addit
found
collect
amount
gag
similar
without
cholesterol
figur
togeth
increas
transduct
effici
suggest
viral
vector
infect
defin
transduct
effici
per
unit
gag
rather
amount
vector
produc
increas
cholesterol
supplement
test
differ
stabil
vector
produc
cultur
without
cholesterol
viral
vector
incub
differ
period
time
use
transduct
result
figur
show
vector
produc
without
cholesterol
supplement
decay
similar
rate
amount
vector
prior
incub
yield
transduct
effici
condit
higher
transduct
effici
time
zero
result
smaller
decay
rate
effect
expect
transduct
effici
increas
linearli
amount
viral
vector
conclus
retrovir
vector
stabil
chang
cholesterol
supplement
vector
product
determin
effect
cholesterol
supplement
plasma
membran
composit
cell
differ
class
phospholipid
extract
untransfect
cell
membran
separ
thin
layer
chromatographi
measur
analysi
phosphor
content
phospholipid
head
group
composit
chang
significantli
cholesterol
supplement
figur
next
measur
cholesterol
content
untransfect
cell
without
cholesterol
addit
preliminari
result
show
free
total
cholesterol
content
increas
time
incub
cholesterol
increas
untransfect
cell
data
shown
base
result
measur
cholesterol
content
transfect
produc
cell
cholesterol
supplement
increas
free
cholesterol
total
cholesterol
produc
cell
figur
longer
produc
cell
cultur
cholesterol
higher
cholesterol
content
free
total
cholesterol
content
greater
control
cell
time
transfect
incub
cholesterol
transfect
interestingli
cholesterol
content
produc
cell
without
cholesterol
supplement
vari
much
transfect
effect
cholesterol
product
lentivir
vector
induc
packag
cell
line
suspens
cultur
also
evalu
similar
case
retrovir
vector
product
addit
cholesterol
induct
gave
highest
titer
lentivir
vector
data
shown
concentr
mm
cholesterol
supplement
higher
concentr
cholesterol
caus
cell
death
data
shown
foldchang
gag
protein
titer
infect
lentivir
vector
produc
cholesterol
supplement
rel
without
cholesterol
list
tabl
similar
retrovir
vector
product
cholesterol
supplement
increas
lentivir
vector
infect
defin
especi
nd
collect
increas
gag
protein
level
cholesterol
addit
much
less
increas
infect
lentivir
vector
stabil
evalu
sever
studi
investig
associ
lipid
raft
assembl
infect
murin
leukemia
viru
envelop
protein
amphotrop
murin
leukemia
viru
shown
coloc
deterg
resist
microdomain
addit
lu
et
al
demonstr
associ
ecotrop
mlv
receptor
raft
import
earli
stage
viru
infect
demonstr
momulv
gag
also
preferenti
local
lipid
raft
cell
commonli
use
produc
momulv
vector
figur
therefor
postul
modul
lipid
raft
composit
produc
cell
membran
could
possibl
affect
assembl
infect
pantrop
retrovir
vector
alter
composit
produc
cell
membran
supplement
growth
media
cholesterol
major
compon
lipid
raft
momulv
vector
product
cholesterol
content
produc
cell
increas
directli
consequ
cholesterol
supplement
figur
viral
vector
produc
cholesterol
supplement
higher
infect
compar
without
cholesterol
addit
figur
although
deplet
cholesterol
virusproduc
cell
could
disrupt
lipid
raft
hinder
viral
particl
product
decreas
viru
infect
cholesterol
amount
produc
cell
without
cholesterol
supplement
decreas
vector
product
figur
thu
supplement
cholesterol
act
restor
defici
produc
cell
rather
increas
cholesterol
content
increas
infect
vector
assembl
bud
raft
possibl
alter
cellular
lipid
raft
composit
consequ
also
possibl
lipid
composit
vial
vector
chang
similar
observ
beer
et
al
led
chang
viral
vector
membran
fluiditi
known
lipid
fatti
acid
composit
tend
chang
offset
associ
chang
membran
fluiditi
certain
circumst
low
temperatur
case
increas
cholesterol
content
might
trigger
chang
membran
fatti
acid
composit
report
level
polyunsatur
speci
major
cell
membran
phospholipid
increas
incorpor
cholesterol
adapt
mechan
control
membran
fluiditi
consist
decreas
satur
fatti
acid
content
major
phospholipid
pc
cholesterol
supplement
studi
data
shown
anoth
possibl
mechan
alter
cellular
lipid
raft
composit
greater
fraction
vector
particl
contain
viral
rna
assembl
bud
true
higher
percentag
viral
vector
produc
cholesterol
supplement
would
becom
infecti
compar
without
cholesterol
addit
variou
cholesterol
addit
scheme
compar
transient
vector
product
system
among
cholesterol
addit
method
supplement
cholesterol
transfect
induct
gave
vector
highest
transduct
effici
therefor
propos
produc
cell
need
certain
amount
time
incorpor
perhap
importantli
process
cholesterol
order
produc
vector
higher
infect
studi
two
differ
sera
fb
fp
supplement
retrovir
vector
product
gener
benefici
effect
cholesterol
supplement
higher
use
fb
compar
fp
figur
interestingli
also
observ
fp
higher
concentr
total
cholesterol
compar
fb
observ
benefit
cholesterol
supplement
transduct
effici
due
effect
produc
cell
rather
directli
viral
vector
incub
cholesterol
viral
vector
product
increas
overal
transduct
effici
figur
similarli
effect
transduct
effici
ad
cholesterol
directli
transduct
medium
result
support
hypothesi
benefici
effect
vector
infect
cholesterol
supplement
happen
vector
assembl
process
andor
bud
produc
cell
membran
shown
other
occur
lipid
raft
produc
cell
cholesterol
supplement
may
increas
fraction
gag
protein
associ
lipid
raft
report
influenza
viru
hemagglutinin
neuraminidas
experi
cholesterol
deliv
complex
mbcd
empti
mbcd
shown
disrupt
lipid
raft
produc
cell
consist
studi
viru
addit
mm
mbcd
produc
cell
greatli
decreas
transduct
effici
pantrop
retrovir
vector
figur
final
benefici
effect
cholesterol
supplement
vector
product
vector
infect
observ
pantrop
momulv
retrovir
vector
pantrop
lentivir
vector
although
extent
differ
amount
lentivir
vector
produc
measur
gag
protein
content
increas
nd
collect
cholesterol
supplement
tabl
amount
retrovir
vector
measur
gag
protein
gag
content
affect
figur
also
greater
increas
vector
infect
cholesterol
supplement
lentivir
vector
system
differ
may
due
part
differ
two
product
system
retrovir
vector
product
system
transient
produc
cell
adher
contrast
lentivir
vector
product
induc
produc
cell
suspens
may
also
inher
differ
differ
vector
taken
togeth
transduct
effici
titer
two
vsvg
pseudotyp
viral
vector
momulv
lentivir
vector
increas
cholesterol
supplement
benefit
mainli
due
increas
vector
infect
combin
method
improv
viral
vector
product
result
studi
contribut
improv
qualiti
vector
product
research
clinic
purpos
effect
cholesterol
supplement
transduct
effici
te
cell
use
either
fb
fp
b
serum
concentr
mm
cholesterol
ad
period
piii
figur
rang
te
valu
obtain
use
differ
volum
viral
vector
transduc
target
cell
valu
normal
control
condit
collect
volum
viral
vector
produc
without
cholesterol
supplement
use
transduc
cell
cholesterol
supplement
vector
product
effect
transduct
effici
use
vector
nd
collect
supplement
vector
product
mm
cholesterol
ad
one
hour
transduct
viral
vector
produc
control
condit
supplement
transduct
cholesterol
ad
transduct
supplement
product
cholesterol
ad
produc
cell
transfect
valu
normal
control
condit
nd
collect
volum
viral
vector
produc
without
cholesterol
supplement
use
transduc
cell
data
point
repres
mean
sd
effect
ad
mbcd
alon
vector
product
transduct
effici
use
vector
nd
collect
mbcd
concentr
mm
use
cholesterol
supplement
ad
either
alon
mm
mbcd
complex
cholesterol
mm
cholesterol
cell
vector
product
insert
figur
repres
result
mm
unload
mbcd
ad
cell
hour
nd
collect
valu
normal
control
condit
nd
collect
volum
viral
vector
produc
without
cholesterol
supplement
use
transduc
cell
data
point
repres
mean
sd
result
shown
separ
cultur
low
high
transduct
effici
control
condit
comparison
stabil
retrovir
vector
produc
without
cholesterol
supplement
momulv
vector
incub
differ
period
time
use
transduct
xaxi
repres
transduct
effici
vector
without
incub
yaxi
repres
vector
decay
rate
obtain
experi
total
cholesterol
tc
free
cholesterol
fc
content
transfect
cell
without
mm
cholesterol
supplement
vector
product
cholesterol
ad
period
piii
figur
valu
normal
total
cholesterol
amount
control
condit
prior
transfect
data
point
repres
mean
sd
tabl
effect
cholesterol
dose
addit
time
transduct
effici
cell
valu
normal
control
condit
collect
volum
viral
vector
produc
without
cholesterol
supplement
use
transduc
cell
data
repres
mean
sd
cholesterol
supplement
period
piii
figur
transduct
effici
control
condit
b
mm
cholesterol
ad
period
p
andor
ii
variou
combin
transduct
effici
control
condit
